CEP290 Antikörper (C-Term)
Kurzübersicht für CEP290 Antikörper (C-Term) (ABIN1106670)
Target
Alle CEP290 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with Mouse 290 kDa Cep290 protein.
-
Kreuzreaktivität (Details)
-
Species reactivity (expected):Rat, Human.
Species reactivity (tested):Mouse. -
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- Synthetic peptide derived from C-terminal domain of Mouse Cep290.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Restore in distilled water.
-
Buffer
- 0.1 M Tris, 0.1 M Glycine and 2 % Sucrose, None
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Prior to reconstitution store the antibody at -20 °C. Store reconstituted antibody at 2-8 °C for one month or (in aliquots) at -20 °C for longer
-
-
- CEP290 (Centrosomal Protein 290kDa (CEP290))
-
Andere Bezeichnung
- CEP290
-
Hintergrund
- CEP290 activates ATF4 mediated transcription and is required for the correct localization of ciliary and phototransduction proteins in retinal photoreceptor cells, may play a role in ciliary transport processes. CEP290 is ubiquitously expressed, strongly in placenta and weakly in brain. There are two named isoforms. Defects in CEP290 are a cause of Joubert syndrome type 5 (JBTS5) [MIM:610188], Senior-Loken syndrome type 6 (SLSN6) [MIM:610189], Leber congenital amaurosis type 10 (LCA10) [MIM:611755] and Meckel syndrome type 4 (MKS4) [MIM:611134]. Antibodies against CEP290 are present in sera from patients with cutaneous T cell lymphomas, but not in the healthy control population.Synonyms: CT87, Cancer/testis antigen 87, Centrosomal protein of 290 kDa, KIAA0373, NPHP6, Nephrocystin-6, Tumor antigen se2-2, se2-2
-
Gen-ID
- 216274
-
NCBI Accession
- NP_666121
-
Pathways
- cAMP Metabolic Process, M Phase
Target
-